18
https://pubmed.ncbi.nlm.nih.gov/38113633
The HALP score, a pretreatment systemic inflammatory marker, is associated with both progression-free and overall survival in endometrial cancer patients.
https://pubmed.ncbi.nlm.nih.gov/38113633
The HALP score, a pretreatment systemic inflammatory marker, is associated with both progression-free and overall survival in endometrial cancer patients.